Active, Not Recruiting
Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
NCT06034470
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +19 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States